EULAR 2022

Treatment with bimekizumab beneficial in psoriatic arthritis

Presented By

Prof. Iain McInnes, Glasgow University, UK

Trial

Phase 3, BE OPTIMAL

Conference

EULAR 2022

9 June, 2022 14:41

IL-6 inhibition successful in treating polymyalgia rheumatica

Presented By

Prof. Bhaskar Dasgupta, Anglia Ruskin University, UK

Trial

Phase 3, SAPHYR

Conference

EULAR 2022

9 June, 2022 14:39

High morbidity in pregnant lupus patients and their unborn children

Presented By

Prof. Bella Mehta, Weill Cornell Medical College, USA

Conference

EULAR 2022

9 June, 2022 14:37

Sexual dysfunction prevalent in RA and PsA patients

Presented By

Dr Carlos Valera-Ribera, Doctor Peset University Hospital, Spain

Conference

EULAR 2022

9 June, 2022 14:35

Fitness trackers reveal a low level of physical activity in patients with musculoskeletal disease

Presented By

Honoria Ocagli, University of Padova, Italy

Conference

EULAR 2022

9 June, 2022 14:32

Global safety report data show more VTE events on JAK inhibition in RA

Presented By

Prof. Adeline Ruyssen-Witrand, University Hospital of Toulouse III Paul Sabatier, France

Conference

EULAR 2022

8 June, 2022 11:58

TYK2 inhibition: A rising star in lupus therapy?

Presented By

Prof. Eric Morand, Monash University, Australia

Trial

Phase 2, PAISLEY

Conference

EULAR 2022

8 June, 2022 11:55

Steep increase of mortality in RA patients with comorbid depression

Presented By

Dr Jens Kristian Pedersen, Odense University Hospital, Denmark

Conference

EULAR 2022

8 June, 2022 11:52

Antifibrotic therapy also effective in patients with negative prognostic factors for lung function decline

Presented By

Prof. Christopher  Denton, University College London, UK

Trial

SENSCIS

Conference

EULAR 2022

8 June, 2022 11:49

Worse psychological symptoms in IBD patients with concomitant fibromyalgia

Presented By

Dr Laura Guida, Luigi Sacco University Hospital, Italy

Conference

EULAR 2022

8 June, 2022 11:41

JAK inhibitor shows to be effective in non-radiographic axSpA

Presented By

Prof. Filip van den Bosch, Ghent University, Belgium

Trial

Phase 3, SELECT-AXIS-2

Conference

EULAR 2022

7 June, 2022 15:38

Tapering TNF blockers in axSpA and psoriatic arthritis: a successful approach

Presented By

Dr Celia Michielsens, Radboud Institute for Health Sciences,  the Netherlands

Conference

EULAR 2022

7 June, 2022 15:36

Baricitinib shows great potential in juvenile idiopathic arthritis

Presented By

Prof. Athimalaipet Ramanan, Bristol Medical School, UK

Trial

Phase 3, JUVE-BASIS

Conference

EULAR 2022

7 June, 2022 15:33

Unexpected comorbidity in patients with knee and hip osteoarthritis

Presented By

Dr Anne Kamps, Erasmus University Medical Center, the Netherlands

Trial

Cohort study

Conference

EULAR 2022

7 June, 2022 15:31

RA: Several risk factors identified for incident dementia

Presented By

Dr Elena Myasoedova, Mayo Clinic, USA

Trial

Cohort study

Conference

EULAR 2022

7 June, 2022 15:25